Skip to content
ppharmaranks
Menu
Class IOngoing

MR. 7 SUPER 700000 capsules recall

FDA recall D-0397-2026 · initiated Dec 15, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 11, 2026How we research

StuffbyNainax recalled MR. 7 SUPER 700000 capsules in Dec 2025 — an FDA Class I recall (D-0397-2026) because Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

Sold unapproved, or found to contain something undeclared

The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

All codes; Exp 12/31/2029

Quantity recalled: 4

Details

Product
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Recalling company
StuffbyNainax
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Product was distributed to 4 customers in the US.
Initiated
Dec 15, 2025
FDA report date
Mar 11, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was MR. 7 SUPER 700000 capsules recalled?
StuffbyNainax recalled MR. 7 SUPER 700000 capsules in Dec 2025 — an FDA Class I recall (D-0397-2026) because Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil. Most serious — a reasonable probability that use will cause serious harm or death.
Why was MR. 7 SUPER 700000 capsules recalled?
Per the FDA enforcement record, the reason for recall D-0397-2026 was: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
Is a recalled MR. 7 SUPER 700000 capsules dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of MR. 7 SUPER 700000 capsules are affected?
Distributed: Product was distributed to 4 customers in the US.. The recall covers these lots — All codes; Exp 12/31/2029. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0397-2026.

Source: openFDA Drug Enforcement record D-0397-2026

← All drug recalls